Nuclear Dishevelled Targets Gene Regulatory Regions and Promotes Tumor Growth
Overview
Authors
Affiliations
Dishevelled (DVL) critically regulates Wnt signaling and contributes to a wide spectrum of diseases and is important in normal and pathophysiological settings. However, how it mediates diverse cellular functions remains poorly understood. Recent discoveries have revealed that constitutive Wnt pathway activation contributes to breast cancer malignancy, but the mechanisms by which this occurs are unknown and very few studies have examined the nuclear role of DVL. Here, we have performed DVL3 ChIP-seq analyses and identify novel target genes bound by DVL3. We show that DVL3 depletion alters KMT2D binding to novel targets and changes their epigenetic marks and mRNA levels. We further demonstrate that DVL3 inhibition leads to decreased tumor growth in two different breast cancer models in vivo. Our data uncover new DVL3 functions through its regulation of multiple genes involved in developmental biology, antigen presentation, metabolism, chromatin remodeling, and tumorigenesis. Overall, our study provides unique insight into the function of nuclear DVL, which helps to define its role in mediating aberrant Wnt signaling.
Dishevelled localization and function are differentially regulated by structurally distinct sterols.
Sengupta S, Yaeger J, Schultz M, Francis K bioRxiv. 2024; .
PMID: 38798572 PMC: 11118412. DOI: 10.1101/2024.05.14.593701.
Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells.
Roy S, Mehta D, Paradkar A, Chovatiya G, Waghmare S Commun Biol. 2024; 7(1):525.
PMID: 38702433 PMC: 11068889. DOI: 10.1038/s42003-024-06047-2.
Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer.
Yi J, Kang T, Han Y, Park H, Yang J, Bae J EMBO Rep. 2023; 24(8):e56335.
PMID: 37341560 PMC: 10398657. DOI: 10.15252/embr.202256335.
Li Z, Yang Z, Liu W, Zhu W, Yin L, Han Z J Transl Med. 2023; 21(1):302.
PMID: 37147666 PMC: 10161491. DOI: 10.1186/s12967-023-04120-8.
Rasha F, Boligala G, Yang M, Martinez-Marin D, Castro-Piedras I, Furr K BMC Cancer. 2023; 23(1):172.
PMID: 36809986 PMC: 9942370. DOI: 10.1186/s12885-023-10647-2.